The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
New progress of immunotherapies for advanced renal cell cancer
Author(s): 
Pages: 65-68
Year: Issue:  2
Journal: World Clinical Drugs

Keyword:  renal cell cancer(RCC)immunotherapytargeted therapyvaccine;
Abstract: Renal cell cancer(RCC)is the common malignant in urology. For early stage, the main treatment is radical nephrectomy. However, RCC is insensitive to chemotherapy and radiotherapy in late stage. Major progresses in the treatment of metastatic RCC patients have been made through biological treatment of tumor. This review summarizes recent progress in the clinical research on immune treatment of advanced RCC.
Related Articles
No related articles found